Corteva technology chief reports 20,091 stock units

Some options are already exercisable, while the remaining reported options have vesting dates through February 18, 2028.

Rhea-AI Filing Summary

On October 1, 2026, Corteva, Inc. Chief Technology Officer Reza J. Rasoulpour reported direct holdings of 20,091 common-stock units, representing unvested restricted stock units and related dividend equivalent units. He also reported non-qualified options covering 10,248, 13,340 and 11,854 common shares, exercisable at $9.94, $8.67 and $10.28, respectively. Some options are vested; remaining portions have stated vesting dates through February 18, 2028.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Rasoulpour Reza J.

Role Chief Technology Officer

Type	Security	Shares	Price	Value
holding	Non-Qualified Stock Option (right-to-buy) F2	--	--	--
holding	Non-Qualified Stock Option (right-to-buy) F3	--	--	--
holding	Non-Qualified Stock Option (right-to-buy) F4	--	--	--
holding	Common Stock F1	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (right-to-buy) — 35,442 contracts (Direct); Common Stock — 20,090.7417 shares (Direct)

Footnotes (4)

1. F1. Represents unvested restricted stock units and related dividend equivalent units.
2. F2. This option is fully vested and exercisable.
3. F3. 8,893 options are vested and exercisable. The remaining options will vest on February 20, 2027.
4. F4. 3,951 options are vested and exercisable. The remaining options will vest in two equal installments on on February 18, 2027 and February 18, 2028.

Key Figures

Direct common-stock units represented by unvested restricted stock units and dividend equivalent units: 20,091 units Non-qualified stock option: 10,248 underlying shares; $9.94 exercise price Non-qualified stock option: 13,340 underlying shares; $8.67 exercise price +1 more

4 metrics

Direct common-stock units represented by unvested restricted stock units and dividend equivalent units 20,091 units Reported October 1, 2026

Non-qualified stock option 10,248 underlying shares; $9.94 exercise price Fully vested and exercisable; expires February 28, 2033

Non-qualified stock option 13,340 underlying shares; $8.67 exercise price Expires February 20, 2034

Non-qualified stock option 11,854 underlying shares; $10.28 exercise price Expires February 18, 2035

Key Terms

Non-Qualified Stock Option (right-to-buy), restricted stock units, dividend equivalent units, vested and exercisable

4 terms

Non-Qualified Stock Option (right-to-buy) financial

"Non-Qualified Stock Option (right-to-buy)"

restricted stock units financial

"Represents unvested restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend equivalent units financial

"related dividend equivalent units"

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

vested and exercisable financial

"This option is fully vested and exercisable."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CTVA shares are covered by Reza J. Rasoulpour's reported options?

The three reported non-qualified options cover 10,248, 13,340 and 11,854 common shares, at exercise prices of $9.94, $8.67 and $10.28, respectively. Their expiration dates are February 28, 2033, February 20, 2034, and February 18, 2035, respectively.

When do Reza J. Rasoulpour's CTVA options vest?

The 10,248-option lot is fully vested and exercisable. Of the 13,340-option lot, 8,893 options are vested and exercisable, and the remaining options vest on February 20, 2027. Of the 11,854-option lot, 3,951 are vested and exercisable; the remaining options vest in two equal installments on February 18, 2027 and February 18, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 07:52 PM Accepted by SEC EDGAR 10/05/2026 - 07:51 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rasoulpour Reza J.

(Last) (First) (Middle)

C/O CORTEVA, INC.

9330 ZIONSVILLE ROAD

(Street)

INDIANAPOLIS INDIANA 46268

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
10/01/2026

3. Issuer Name and Ticker or Trading Symbol
Corteva, Inc. [ CTVA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	20,090.7417(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy)	(2)	02/28/2033	Common Stock	10,248	$9.94	D
Non-Qualified Stock Option (right-to-buy)	(3)	02/20/2034	Common Stock	13,340	$8.67	D
Non-Qualified Stock Option (right-to-buy)	(4)	02/18/2035	Common Stock	11,854	$10.28	D

Explanation of Responses:

1. Represents unvested restricted stock units and related dividend equivalent units.

2. This option is fully vested and exercisable.

3. 8,893 options are vested and exercisable. The remaining options will vest on February 20, 2027.

4. 3,951 options are vested and exercisable. The remaining options will vest in two equal installments on on February 18, 2027 and February 18, 2028.

	/s/Abigail Jarrell, by power of attorney	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)